E. Nadal

541 total citations
20 papers, 254 citations indexed

About

E. Nadal is a scholar working on Epidemiology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E. Nadal has authored 20 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Hepatology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E. Nadal's work include Liver Disease and Transplantation (9 papers), Liver Disease Diagnosis and Treatment (9 papers) and Organ Transplantation Techniques and Outcomes (3 papers). E. Nadal is often cited by papers focused on Liver Disease and Transplantation (9 papers), Liver Disease Diagnosis and Treatment (9 papers) and Organ Transplantation Techniques and Outcomes (3 papers). E. Nadal collaborates with scholars based in Italy, Spain and United States. E. Nadal's co-authors include Marco Senzolo, Patrizia Burra, K. Rodriguez-Castro, Giacomo Germani, Robert J. Porte, Giacomo Carlo Sturniolo, R. D’Incà, A K Burroughs, Andrea Buda and Walter Fries and has published in prestigious journals such as Journal of Hepatology, Annals of Oncology and The American Journal of Gastroenterology.

In The Last Decade

E. Nadal

18 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Nadal Italy 6 209 171 119 26 13 20 254
Brian Hogan United Kingdom 10 196 0.9× 134 0.8× 196 1.6× 24 0.9× 12 0.9× 33 322
Carmen Vinaixa Spain 9 451 2.2× 399 2.3× 100 0.8× 13 0.5× 18 1.4× 24 491
Giovanni Talerico Italy 7 194 0.9× 189 1.1× 81 0.7× 52 2.0× 30 2.3× 11 310
Justine Hum United States 9 274 1.3× 223 1.3× 82 0.7× 61 2.3× 68 5.2× 11 365
Freeha Arshad Netherlands 6 237 1.1× 158 0.9× 118 1.0× 41 1.6× 54 4.2× 10 300
Aftab Mohsin Pakistan 4 163 0.8× 144 0.8× 64 0.5× 38 1.5× 15 1.2× 6 328
Frances Sheppard France 7 171 0.8× 174 1.0× 61 0.5× 33 1.3× 20 1.5× 8 281
Ismael Yepes Spain 5 329 1.6× 260 1.5× 117 1.0× 25 1.0× 70 5.4× 10 369
Bashar Hmoud United States 7 318 1.5× 259 1.5× 218 1.8× 5 0.2× 16 1.2× 10 450
Teresa Binter Austria 9 187 0.9× 169 1.0× 34 0.3× 11 0.4× 9 0.7× 23 242

Countries citing papers authored by E. Nadal

Since Specialization
Citations

This map shows the geographic impact of E. Nadal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Nadal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Nadal more than expected).

Fields of papers citing papers by E. Nadal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Nadal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Nadal. The network helps show where E. Nadal may publish in the future.

Co-authorship network of co-authors of E. Nadal

This figure shows the co-authorship network connecting the top 25 collaborators of E. Nadal. A scholar is included among the top collaborators of E. Nadal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Nadal. E. Nadal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soo, Ross A., E. Nadal, Yi‐Long Wu, et al.. (2025). PT2.12.03 Zongertinib in Patients With Previously Treated HER2-Mutant NSCLC and Brain Metastases at Baseline: Beamion LUNG-1. Journal of Thoracic Oncology. 20(10). S613–S614.
2.
Yamamoto, Norio, Yi‐Long Wu, Hai‐Yan Tu, et al.. (2025). LBA74 Zongertinib as first-line treatment in patients with advanced HER2-mutant NSCLC: Beamion LUNG 1. Annals of Oncology. 36. S1616–S1616.
3.
Granados, Ana Laura Ortega, Federico Rojo, Luis Cabezón‐Gutiérrez, et al.. (2020). PCN95 Clinical and Economic IMPACT of ALK Rearrangement Testing in Advanced NSCLC in Spain Compared with a Hypothetical NO-Testing Scenario. Value in Health. 23. S439–S439. 1 indexed citations
4.
5.
Nadal, E., Paolo Simioni, Luca Spiezia, et al.. (2017). Thromboelastographic evaluation of hemostatic balance in cirrhotic patients with infection. Digestive and Liver Disease. 49(1). e55–e55. 1 indexed citations
6.
Zanetto, Alberto, Alberto Ferrarese, E. Nadal, et al.. (2016). Circulating Microparticles and Risk of Portal Vein Thrombosis in Patients with Liver Cirrhosis and Hepatocellular Carcinoma. Journal of Hepatology. 64(2). S246–S246. 1 indexed citations
7.
Nadal, E., et al.. (2016). Pancreatic melanoma metastasis diagnosed by endoscopic ultrasound-guided SharkCore biopsy. Endoscopy. 48(S 01). E208–E209. 6 indexed citations
8.
Germani, Giacomo, Alberto Ferrarese, Alberto Zanetto, et al.. (2015). PREVALENCE AND RISK FACTORS OF METABOLIC SYNDROME AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE. Digestive and Liver Disease. 47. e52–e52. 1 indexed citations
9.
Germani, Giacomo, Alberto Ferrarese, Alberto Zanetto, et al.. (2015). P0074 : Prevalence and risk factors of metabolic syndrome after liver transplantation: a single centre experience. Journal of Hepatology. 62. S320–S320. 2 indexed citations
10.
Ferrarese, Alessia, Alberto Zanetto, P. Angeli, et al.. (2014). EFFECTS OF NON-SELECTIVE beta-BLOCKERS ON HEMODYNAMICS AFTER LARGE VOLUME PARACENTESIS IN PATIENTS WITH CIRRHOSIS LISTED FOR LIVER TRANSPLANTATION: A PRELIMINARY REPORT. Transplant International. 27. 13–13. 1 indexed citations
11.
Ferrarese, Alberto, Giacomo Germani, K. Rodriguez-Castro, et al.. (2014). OC.19.2 BLEEDING-UNRELATED MORTALITY IS NOT INCREASED IN PATIENTS WITH CIRRHOSIS AND ASCITES ON TREATMENT WITH β-BLOCKERS: A META-ANALYSIS. Digestive and Liver Disease. 46. S41–S41. 2 indexed citations
12.
Radu, Claudia Maria, Sabrina Gavasso, P. Zerbinati, et al.. (2013). 235 PREDICTORS OF RESPONSE TO ANTICOAGULANT THERAPY FOR THE TREATMENT OF PORTAL VEIN THROMBOSIS (PVT) IN CIRRHOSIS PATIENTS. Journal of Hepatology. 58. S101–S101. 1 indexed citations
13.
Gambato, Martina, Anna Chiara Frigo, Marco Senzolo, et al.. (2013). Who Fares Worse After Liver Transplantation? Impact of Donor and Recipient Variables on Outcome. Transplantation. 95(12). 1528–1534. 13 indexed citations
14.
Rodriguez-Castro, K., Robert J. Porte, E. Nadal, et al.. (2012). Management of Nonneoplastic Portal Vein Thrombosis in the Setting of Liver Transplantation. Transplantation. 94(11). 1145–1153. 164 indexed citations
15.
Nadal, E., et al.. (2011). 610 FUNCTIONAL STUDY OF THE INTESTINAL BARRIER IN PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSION. Journal of Hepatology. 54. S247–S248. 1 indexed citations
16.
Senzolo, Marco, et al.. (2010). ALGORITHM FOR THE MANAGEMENT OF PORTAL VEIN THROMBOSIS (PVT) IN PATIENTS WITH CIRRHOSIS: A PROSPECTIVE CASE-CONTROL STUDY. UCL Discovery (University College London). 4 indexed citations
17.
Germani, Giacomo, Francesca Gnoato, Marco Senzolo, et al.. (2010). Does Once-Daily Tacrolimus (Advagraf) Increase Adherence to Immunosuppressive Therapy in Liver Transplanted Patients?. Research Padua Archive (University of Padua). 16. 1 indexed citations
18.
Germani, Giacomo, Francesca Gnoato, Egle Perissinotto, et al.. (2010). 473 NON ADHERENCE TO MEDICAL PRESCRIPTIONS IN LIVER TRANSPLANTATION: A PROSPECTIVE LONGITUDINAL STUDY. Journal of Hepatology. 52. S191–S192. 1 indexed citations
19.
Senzolo, Marco, Walter Fries, Andrea Buda, et al.. (2009). Oral Propranolol Decreases Intestinal Permeability in Patients With Cirrhosis. The American Journal of Gastroenterology. 104(12). 3115–3116. 31 indexed citations
20.
Roca, Bernardino, et al.. (2003). Usefulness of a Hypertension Education Program. Southern Medical Journal. 96(11). 1133–1137. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian Hogan Breakdown of academic impact, for papers by Carmen Vinaixa Breakdown of academic impact, for papers by Giovanni Talerico Breakdown of academic impact, for papers by Justine Hum Breakdown of academic impact, for papers by Freeha Arshad Breakdown of academic impact, for papers by Aftab Mohsin Breakdown of academic impact, for papers by Frances Sheppard Breakdown of academic impact, for papers by Ismael Yepes Breakdown of academic impact, for papers by Bashar Hmoud Breakdown of academic impact, for papers by Teresa Binter
Rankless by CCL
2026